Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
BMC Infect Dis ; 21(1): 524, 2021 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-34088268

RESUMEN

BACKGROUND: With pandemic of coronavirus disease 2019 (COVID-19), human coronaviruses (HCoVs) have recently attached worldwide attention as essential pathogens in respiratory infection. HCoV-229E has been described as a rare cause of lower respiratory infection in immunocompetent adults. CASE PRESENTATION: We reported a 72-year-old man infected by HCoV-229E with rapid progression to acute respiratory distress syndrome, in conjunction with new onset atrial fibrillation, intensive care unit acquired weakness, and recurrent hospital acquired pneumonia. Clinical and radiological data were continuously collected. The absolute number of peripheral T cells and the level of complement components diminished initially and recovered after 2 months. The patient was successfully treated under intensive support care and discharged from the hospital after 3 months and followed. CONCLUSION: HCoV-229E might an essential causative agent of pulmonary inflammation and extensive lung damage. Supportive treatment was essential to HCoVs infection on account of a long duration of immunological recovery in critical HCoV-229E infection.


Asunto(s)
Resfriado Común/diagnóstico , Coronavirus Humano 229E , Infecciones por Coronavirus/diagnóstico , Neumonía Viral/diagnóstico , Anciano , Antibacterianos/uso terapéutico , Líquido del Lavado Bronquioalveolar/virología , Resfriado Común/complicaciones , Resfriado Común/virología , Infecciones por Coronavirus/complicaciones , Diabetes Mellitus , Neumonía Asociada a la Atención Médica/complicaciones , Neumonía Asociada a la Atención Médica/tratamiento farmacológico , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Masculino , Neumonía Viral/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA